UNC Project-Malawi Cancer
WHY MALAWI?
The UNC Project- Malawi Cancer Program is well-positioned to catalyze a broad, coordinated cancer control effort in Malawi, and address key scientific questions related to cancer in sub-Saharan Africa. Read More
OUR PRIORITIES
We aim to develop sufficient internal capacity such that Malawi can become a leader of cancer care and research in low-resource settings, as it has long been for HIV care and treatment. Read More
OUR PARTNERS
Collaboration is an important component of what we do and our success is supported by a remarkable cancer research network of diverse and accomplished partner institutions. Read More
Recent Scientific Outputs
-
Case Report: Multicentric Castleman Disease as a Manifestation of Immune Reconstitution Inflammatory Syndrome in Malawi
December 2022 INTRODUCTION Multicentric Castleman disease (MCD) is a lymphoproliferative disorder characterized by systemic inflammation, lymphadenopathy, and cytopenias. MCD caused by Kaposi sarcoma herpesvirus (MCD-KSHV) frequently arises in the context of HIV. It can be associated with immune reconstitution inflammatory syndrome (IRIS), but MCD-IRIS is rarely reported in sub-Saharan Africa (SSA) where HIV and KSHV … Read more
-
Tobacco and Other Risk Factors for Esophageal Squamous Cell Carcinoma in Lilongwe Malawi: Results from The Lilongwe Esophageal Cancer Case: Control Study
June 2022 OBJECTIVE Esophageal cancer is the second commonest cancer in Malawi, and 95% of all cases are esophageal squamous cell carcinoma (ESCC). Very little is known about the epidemiology of ESCC in Malawi including risk factors. The main objective of the study was to evaluate and describe risk factors of ESCC in Malawi. METHODS … Read more
-
African Esophageal Cancer Consortium (AfrECC). Treatment Outcomes of Esophageal Cancer in Eastern Africa: Protocol of a Multi-Center, Prospective, Observational, Open Cohort Study
January 2022 BACKGROUND Esophageal squamous cell carcinoma (ESCC) is a major cause of cancer morbidity and mortality in Eastern Africa. The majority of patients with ESCC in Eastern Africa present with advanced disease at the time of diagnosis. Several palliative interventions for ESCC are currently in use within the region, including chemotherapy, radiation therapy with … Read more
Recent News
-
6th Annual Malawi Cancer Symposium
We hosted the 6th Annual Malawi Cancer Symposium on 4-5 September 2024 at BICC. The successful symposium provided a platform for both local and international cancer research, care and advocacy stakeholders to exchange information, highlight strategic priorities and identify opportunities for collaboration, personal development, and training with the common goal of reducing the burden of … Read more
-
5th Annual Malawi Cancer Symposium
The 5th Annual Malawi Cancer Symposium was held Sept 6-7 at the Bingu International Convention Centre (BICC) in Lilongwe. Organized by the Malawi Ministry of Health in collaboration with the UNC Institute for Global Health and Infectious Diseases, the UNC Lineberger Comprehensive Cancer Center, and UNC Project Malawi Cancer Program, the event provided a … Read more
-
DR. MPONDA TO PRESENT AT THE 2022 ASH ANNUAL MEETING AND EXPOSITION
Dr. Marriam Mponda has been selected to present at the upcoming 64th annual meeting and exposition that will take place on December 10-13, 2022, in New Orleans, Louisiana, USA. Dr. Mponda will be presenting her poster entitled, “ABVD for Hodgkin Lymphoma in Malawi: Excellent Outcomes but with Persistent Clinical Disparities Compared to High Income Countries: … Read more
